Life

Health, science, climate, and society-focused reporting.

Current Trends in MAHA: Breakthroughs and Challenges

Recent updates on MAHA highlight a significant breakthrough in Duchenne muscular dystrophy, alongside ongoing challenges in cancer treatment and other health developments.

Editorial Staff Apr 8

Life

Reviving Hope: A Mother's Fight for Neuromuscular Drug Class

A mother's determination has reignited interest in a neglected class of drugs, potentially benefiting her son and many others with neuromuscular disorders.

Editorial Staff Apr 8

Life

Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review

A federal judge Tuesday refused to block filling prescriptions for the abortion pill mifepristone by mail across the U.S. — at least for now.

Editorial Staff Apr 8

Life

Tracking Key Mental Health and Substance Use Policy Actions Under the Trump Administration

Strategic angle: A new KFF tracker highlights key federal policy actions during President Trump’s second term that concern issues related to mental health and substance use.

Editorial Staff Apr 7

Life

KFF Tracker: America First MOU Bilateral Global Health Agreements

Strategic angle: This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S.

Editorial Staff Apr 7

Life

Novo Nordisk launches high-dose Wegovy

Strategic angle: Insurers score Medicare Advantage wins, the obesity drug race continues, and other biotech news from The Readout.

Editorial Staff Apr 7

Life

Measles Elimination Status: What It Is and How the U.S. Could Lose It

Strategic angle: This policy watch examines the United States’ measles elimination status and the potential threats to it.

Editorial Staff Apr 7

Life

States looking to regulate use of chatbots

Strategic angle: In this edition of STAT Health Tech: UnitedHealth Group's big bet on AI to transform its operations, venture funding trends, and more.

Editorial Staff Apr 7

Life

Trump Budget’s ‘America First’ Drug Policy Proposals

Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.

Editorial Staff Apr 7

Life

Many cancer patients don’t get genomic tests to guide treatment, study finds

Strategic angle: Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.

Editorial Staff Apr 7

Life

FDA Seeks to Strengthen Domestic Drug Manufacturing Through New Proposals

In a move to enhance local drug production, the FDA has proposed new policies as part of the president's budget, aiming to support domestic drug development.

Editorial Staff Apr 7

Life

Health insurers score major win with higher 2027 Medicare Advantage rates

The stocks of major Medicare Advantage insurers surged on the announcement.

Editorial Staff Apr 7

Life

Capping Insulin Costs at $35 May Improve Treatment Adherence for Type 2 Diabetes

A recent study suggests that limiting insulin prices to $35 per month could enhance adherence to treatment among individuals with type 2 diabetes, highlighting the potential impact of cost on health outcomes.

Editorial Staff Apr 7

Life

Gilead Acquires Tubulis for Over $3 Billion to Boost Oncology Portfolio

In a significant move to enhance its oncology pipeline, Gilead has announced the acquisition of Tubulis, a German biotech firm, for more than $3 billion.

Editorial Staff Apr 7

Life

Merck's HIV Prevention Pill: A Cost-Effective Solution Awaiting Generic Production

With estimates suggesting Merck's experimental HIV prevention pill could cost under $5 annually, researchers are calling for the company to allow generic production.

Editorial Staff Apr 7

Life

Double Bonuses Increased MA Spending In Puerto Rico By $865 Million But Did Not Achieve Plan Improvement Goals

Strategic angle: A study published in Health Affairs reveals the financial impact of double bonuses on Medicare Advantage spending in Puerto Rico.

Editorial Staff Apr 7

Life

Drug Prices, Behavioral Health, Hospitals, And More

Strategic angle: Health Affairs discusses critical issues in healthcare.

Editorial Staff Apr 7

Life

First Year Of ACO Realizing Equity, Access, And Community Health Program Yields Good Quality, Savings Results

Strategic angle: Health Affairs reports positive outcomes from the first year of the ACO program focused on equity and community health.

Editorial Staff Apr 7

Life

Lingering Effects Of The COVID-19 Pandemic On Non-COVID-19 Death Rates In The US, 2020–24

Strategic angle: A comprehensive study examining the impact of the COVID-19 pandemic on death rates from other causes in the United States.

Editorial Staff Apr 7

Life

‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come

Strategic angle: Exploring the implications and potential benefits of implementing a Most Favored Nation drug pricing model.

Editorial Staff Apr 7